Cargando…

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease

Background: There are limited data for non-vitamin K antagonist oral anticoagulants (NOACs) impact on outcomes for patients with atrial fibrillation (AF) and valvular heart diseases (VHDs). Methods: We identified patients with AF and associated Evaluated Heartvalves, Rheumatic or Artificial (EHRA) t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moon, Inki, Lee, So-Ryoung, Choi, Eue-Keun, Lee, Euijae, Jung, Jin-Hyung, Han, Kyung-Do, Cha, Myung-Jin, Oh, Seil, Lip, Gregory Y.H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832302/ https://www.ncbi.nlm.nih.gov/pubmed/31590290 http://dx.doi.org/10.3390/jcm8101624

Ejemplares similares

Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study
por: Lee, So-Ryoung, et al.
Publicado: (2017)

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in octogenarian patients with non-valvular atrial fibrillation
por: Kim, Hyue Mee, et al.
Publicado: (2019)

Prevalence of Non-valvular Atrial Fibrillation Based on Geographical Distribution and Socioeconomic Status in the Entire Korean Population
por: Lee, So-Ryoung, et al.
Publicado: (2018)

Effectiveness and Safety of Direct Oral Anticoagulant for Secondary Prevention in Asians with Atrial Fibrillation
por: Park, Jiesuck, et al.
Publicado: (2019)

Impact of Non-Vitamin K Antagonist Oral Anticoagulants on the Change of Antithrombotic Regimens in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
por: Kwon, Soonil, et al.
Publicado: (2021)

Fluctuating renal function and the risk of incident atrial fibrillation: a nationwide population-based study
por: Kwon, Soonil, et al.
Publicado: (2019)

Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study
por: Choi, You-Jung, et al.
Publicado: (2019)

Temporal Trends of Emergency Department Visits of Patients with Atrial Fibrillation: A Nationwide Population-Based Study
por: Lee, So-Ryoung, et al.
Publicado: (2020)

Association Between Change in Metabolic Syndrome Status and Risk of Incident Atrial Fibrillation: A Nationwide Population‐Based Study
por: Lee, Seo‐Young, et al.
Publicado: (2021)

Acute and long‐term efficacy of ablation index‐guided higher power shorter duration ablation in patients with atrial fibrillation: A prospective registry
por: Lee, So‐Ryoung, et al.
Publicado: (2021)

Efficacy and Safety of Oral Anticoagulants for Atrial Fibrillation Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Rhee, Tae-Min, et al.
Publicado: (2022)

Mortality and causes of death in patients with atrial fibrillation: A nationwide population-based study
por: Lee, Euijae, et al.
Publicado: (2018)

Label Adherence for Non-Vitamin K Antagonist Oral Anticoagulants in a Prospective Cohort of Asian Patients with Atrial Fibrillation
por: Lee, So-Ryoung, et al.
Publicado: (2019)

Chromosomal abnormalities and atrial fibrillation and ischemic stroke incidence: a nationwide population-based study
por: Cho, Jun Hwan, et al.
Publicado: (2020)

Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation
por: Lee, So-Ryoung, et al.
Publicado: (2019)

Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients
por: Li, Yan-Guang, et al.
Publicado: (2018)

Smoking Cessation after Diagnosis of New-Onset Atrial Fibrillation and the Risk of Stroke and Death
por: Lee, So-Ryoung, et al.
Publicado: (2021)

Zero‐fluoroscopy catheter ablation for atrial fibrillation: a transitional period experience
por: Cha, Myung‐Jin, et al.
Publicado: (2020)

High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study
por: Lee, Hyun-Jung, et al.
Publicado: (2020)

Impact of Hemoglobin Levels and Their Dynamic Changes on the Risk of Atrial Fibrillation: A Nationwide Population-Based Study
por: Lim, Woo-Hyun, et al.
Publicado: (2020)

Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study
por: Lee, So-Ryoung, et al.
Publicado: (2021)

Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study
por: Park, Jiesuck, et al.
Publicado: (2019)

Longitudinal Patterns in Antithrombotic Therapy in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention in the Non-Vitamin K Oral Anticoagulant Era: A Nationwide Population-Based Study
por: Park, Jiesuck, et al.
Publicado: (2021)

Entrapment of a steerable diagnostic electrophysiologic catheter in the Thebesian valve during radiofrequency catheter ablation for atrial fibrillation
por: Lee, Euijae, et al.
Publicado: (2020)

Quality of Anticoagulation and Treatment Satisfaction in Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonist: Result from the KORean Atrial Fibrillation Investigation II
por: Oh, Seil, et al.
Publicado: (2018)

Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project
por: Xiong, Qinmei, et al.
Publicado: (2016)

Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study
por: Lee, So-Ryoung, et al.
Publicado: (2021)

Association between Atrial Fibrillation, Myocardial Infarction, Heart Failure and Mortality in Patients with Nontuberculous Mycobacterial Infection: a nationwide population-based study
por: Park, Chan Soon, et al.
Publicado: (2019)

Atrial Innervation Patterns of Intrinsic Cardiac Autonomic Nerves
por: Lee, So-Ryoung, et al.
Publicado: (2018)

Cumulative burden of metabolic syndrome and its components on the risk of atrial fibrillation: a nationwide population-based study
por: Ahn, Hyo-Jeong, et al.
Publicado: (2021)

Clustering of Unhealthy Lifestyle and the Risk of Adverse Events in Patients With Atrial Fibrillation
por: Lee, So-Ryoung, et al.
Publicado: (2022)

Type and Severity of Migraine Determines Risk of Atrial Fibrillation in Women
por: Rhee, Tae-Min, et al.
Publicado: (2022)

Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention
por: Park, Jiesuck, et al.
Publicado: (2020)

Impact of Socioeconomic Status on Emergency Department Visits in Patients With Atrial Fibrillation: A Nationwide Population‐Based Cohort Study
por: Lee, Seo‐Young, et al.
Publicado: (2022)

Increased atrial fibrillation risk in Parkinson’s disease: A nationwide population‐based study
por: Han, Seokmoon, et al.
Publicado: (2021)

Association between the accumulation of elevated serum γ-glutamyltransferase level and risk of atrial fibrillation: a nationwide cohort study
por: Jeon, Won Kyeong, et al.
Publicado: (2023)

Low Lipid Levels and High Variability are Associated With the Risk of New‐Onset Atrial Fibrillation
por: Lee, Hyun‐Jung, et al.
Publicado: (2019)

Impact of components of metabolic syndrome on the risk of adverse renal outcomes in patients with atrial fibrillation: a nationwide cohort study
por: Kwon, Soonil, et al.
Publicado: (2023)

Association between clustering of unhealthy lifestyle factors and risk of new-onset atrial fibrillation: a nationwide population-based study
por: Lee, So-Ryoung, et al.
Publicado: (2020)

Risk of Dementia After Smoking Cessation in Patients With Newly Diagnosed Atrial Fibrillation
por: Lee, Hui-Jin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o6q78g8hmnkcrugn0ouudbthb9